Your browser doesn't support javascript.
loading
Hepatitis B Virus Neutralization with DNA Origami Nanoshells.
Willner, Elena M; Kolbe, Fenna; Momburg, Frank; Protzer, Ulrike; Dietz, Hendrik.
Afiliación
  • Willner EM; Department of Biosciences, School of Natural Sciences and Munich Institute of Biomedical Engineering, Technical University of Munich, Boltzmannstraße 11, 85748 Garching, Germany.
  • Kolbe F; Institute of Virology, School of Medicine & Health, Technical University of Munich and Helmholtz Munich, Trogerstraße 30, 81675 Munich, Germany.
  • Momburg F; Translational Immunity Unit, German Cancer Research Center (DKFZ), Im Neuenheimer Feld, 69120 Heidelberg, Germany.
  • Protzer U; Institute of Virology, School of Medicine & Health, Technical University of Munich and Helmholtz Munich, Trogerstraße 30, 81675 Munich, Germany.
  • Dietz H; German Center for Infection Research (DZIF), Munich Partner Site, 81675 Munich, Germany.
ACS Appl Mater Interfaces ; 16(20): 25836-25842, 2024 May 22.
Article en En | MEDLINE | ID: mdl-38728653
ABSTRACT
We demonstrate the use of DNA origami to create virus-trapping nanoshells that efficiently neutralize hepatitis B virus (HBV) in cell culture. By modification of the shells with a synthetic monoclonal antibody that binds to the HBV envelope, the effective neutralization potency per antibody is increased by approximately 100 times compared to using free antibodies. The improvements in neutralizing the virus are attributed to two factors first, the shells act as a physical barrier that blocks the virus from interacting with host cells; second, the multivalent binding of the antibodies inside the shells lead to stronger attachment to the trapped virus, a phenomenon known as avidity. Pre-incubation of shells with HBV and simultaneous addition of both components separately to cells lead to comparable levels of neutralization, indicating rapid trapping of the virions by the shells. Our study highlights the potential of the DNA shell system to rationally create antivirals using components that, when used individually, show little to no antiviral effectiveness.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: ADN / Virus de la Hepatitis B / Nanocáscaras Idioma: En Revista: ACS Appl Mater Interfaces Asunto de la revista: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: ADN / Virus de la Hepatitis B / Nanocáscaras Idioma: En Revista: ACS Appl Mater Interfaces Asunto de la revista: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Año: 2024 Tipo del documento: Article